0 What influence could genetics have on immunity following vaccination?
A study has revealed genetic variants associated with differing levels of protective antibodies produced after routine immunizations.
Browsing: Clinical > Vaccines
0 First genomic description of global S. pneumoniae population released
A global genomic survey of Streptococcus pneumoniae has identified 621 strains across 50 countries and has highlighted how the bacteria can evolve in response to vaccination.
0 FDA rejects Nabriva’s antibiotic Contepo for complicated UTIs: May’s industry headlines
Take a look at this month’s industry headlines including US FDA approvals for Mavyret (hepatitis C) and Dengvaxia, a rejection for Contepo and profits for Gilead Sciences.
0 Cholera vaccination campaign begins in the Democratic Republic of Congo
Over 800,000 individuals will be vaccinated against cholera in North Kivu, Democratic Republic of Congo, as the area suffers an unprecedented combination of epidemics.
0 Group A Streptococcus sequencing reveals potential targets for a global vaccine
A cohort of scientists from the Wellcome Sanger Institute, the University of Cambridge, the Peter Doherty Institute for Infection and Immunity and the University of Queensland have identified novel targets using DNA sequencing, bringing research one step closer to developing a universal vaccine against Group A Streptococcus.
0 Slow-release delivery strategies provide better immunity for HIV vaccine
Delivering HIV vaccines via slow-release methods has enhanced the protective immune response in preclinical models, according to new research.
0 Positive opinions from US FDA and EMA for ViiV Healthcare’s Dovato®: April’s industry headlines
Take a look at this month’s industry headlines including news from ViiV Healthcare on long-acting and single dose formulations, sales for Eli Lilly and the possible development of a plague vaccine.
0 Ask the Experts: Vaccine confidence in the ‘post-truth’ world
In line with World Immunization Week, we’ve brought together a panel of experts to discuss the issues surrounding vaccine confidence in a ‘post-truth’ world.
0 RTS,S vaccine to enter Phase IV trials in Malawi, Kenya and Ghana
A large-scale trial of RTS,S – the world’s first malaria vaccine to provide partial protection – is due to commence in Malawi, Kenya and Ghana.
0 ECCMID19: Vaccine-preventable diseases on the rise in Venezuela
Vaccine-preventable diseases – including measles and diphtheria – have surged in crisis-hit Venezuela, according to research presented at ECCMID.
